Key facts
- This page summarizes Michael Grissinger's Form 3 filing for Akari Therapeutics Plc (AKTX).
- 0 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2024, 18:41.
Michael Grissinger - 01 Jan 2024 Form 3 Insider Report for Akari Therapeutics Plc (AKTX)
- Reporting relationship
- Director
- Issuer ticker
- AKTX
- Reported as of
- 01 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Jan 2024, 18:41:51 UTC
- Prior SEC filing
- 24 Aug 2023
- Next SEC filing
- 21 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rachelle Jacques, as Attorney-in-Fact for Michael Grissinger
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Grissinger filed Form 3 for Akari Therapeutics Plc (AKTX) on 02 Jan 2024.
Change
- Previous filing in this sequence was filed on 24 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKTX
holding
Ordinary Shares, par value $0.0001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000,000
- Date
- 01 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0347
- Footnotes
- F1
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0208
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0207
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0218
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0173
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 1,300,000
- Exercise price
- $0.0100
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 3,700,000
- Exercise price
- $0.004800
AKTX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value $0.0001 per share
- Underlying amount
- 5,000,000
- Exercise price
- $0.001700
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan. The stock option vested and became exercisable in four equal installments of twenty-five percent (25%), with the with the first installment vesting on January 23, 2019 and an additional 25% vesting on each annual anniversary of the vesting date thereafter.
Footnote F2
Non-qualified stock option granted under the Issuer's 2023 Equity Incentive Plan. One-hundred percent (100%) of the stock option vests and becomes exercisable on the date of the Issuer's 2024 Annual General Meeting.
SEC remarks
See Exhibit 24.1 - Power of Attorney